'Silymarin' a Potential Treatment Targeting Hepatic Fibrosis of Schistosomiasis
Maimonah Alghanmi & Aziza Alrafiah · Journal of Pharmaceutical Research International · 2021
Background: Despite all treatment and control efforts, schistosomiasis still thrives in humanity. It is endemic in 78 countries that are anchored by poverty and diseases. Until now, the broad-spectrum praziquantel (PZQ) drug is the only effective treatment of choice. However, rep...
Open access
Research Article
10.9734/jpri/2021/v33i54B33783